Prognostic value of highly sensitive troponin T on cardiac events in patients with chronic kidney disease not on dialysis
Prognostic value of highly sensitive troponin T on cardiac events in patients with chronic kidney disease not on dialysis
复制标题
高敏肌钙蛋白 T 对非透析慢性肾病患者心脏事件的预后价值
DOI:
10.1007/s00380-012-0273-2
复制
发表时间:
2013
影响因子:
1.5
通讯作者:
Y. Yuzawa
中科院分区:
文献类型:
--
作者:
M. Hasegawa;Junichi Ishii;F. Kitagawa;Kyoko Kanayama;Hiroshi Takahashi;Y. Ozaki;Y. Yuzawa
Serum troponin T levels using a highly sensitive assay (hsTnT) in patients with chronic kidney disease (CKD) not on dialysis have not been examined. The aim of this prospective cohort study was to investigate the association of hsTnT with cardiac events in ambulatory CKD patients not on dialysis. The serum hsTnT level was measured in 442 ambulatory CKD patients not on dialysis whose estimated glomerular filtration rate was <60 ml/min/1.73 m2. Patients were divided into quartiles according to hsTnT levels, and were followed up for 3 years. Cardiac events were defined as a cardiac death, acute myocardial infarction, unstable angina pectoris that required emergency coronary revascularization, or hospitalization for worsening heart failure. During the follow-up period (median 22 months), 63 cardiac events occurred. Kaplan–Meier incidence rates of cardiac events for 3 years were 0.88 %, 11.5 %, 19.0 %, and 41.4 % among quartiles of hsTnT levels (P < 0.0001). After adjusting for other confounders, elevated hsTnT level was an independent predictor for cardiac events (hazard ratio 6.18, 95 % confidence interval 1.38–27.7, P = 0.0080 for highest quartile vs lowest quartile). In addition, C-index for receiver-operating characteristic curves for cardiac events was greater in an established risks plus hsTnT model than in the established risk alone model (0.857 vs 0.844, P = 0.026). Using a highly sensitive assay, serum hsTnT level was shown to be an independent predictor of cardiac events and a promising risk stratification tool in patients with CKD not on dialysis.
DOI:
10.1056/nejmoa0805299
发表时间:
2009-12-24
期刊:
The New England journal of medicine
影响因子:
--
作者:
Omland T;de Lemos JA;Sabatine MS;Christophi CA;Rice MM;Jablonski KA;Tjora S;Domanski MJ;Gersh BJ;Rouleau JL;Pfeffer MA;Braunwald E;Prevention of Events with Angiotensin Converting Enzyme Inhibition (PEACE) Trial Investigators
通讯作者:
Prevention of Events with Angiotensin Converting Enzyme Inhibition (PEACE) Trial Investigators
DOI:
10.1001/jama.2010.1768
发表时间:
2010-12-08
期刊:
JAMA
影响因子:
--
作者:
de Lemos JA;Drazner MH;Omland T;Ayers CR;Khera A;Rohatgi A;Hashim I;Berry JD;Das SR;Morrow DA;McGuire DK
通讯作者:
McGuire DK
影响因子:
120.7
作者:
deFilippi, Christopher R.;de Lemos, James A.;Christenson, Robert H.;Gottdiener, John S.;Kop, Willem J.;Zhan, Min;Seliger, Stephen L.
通讯作者:
Seliger, Stephen L.